Development of a Gonorrhea Vaccine Using the mRNA Platform Established at Afrigen
- Overview of mRNA platform established in Afrigen
- Platform for sustainability with pipeline of disease targets
- Showcasing mRNA Gonorrhea vaccine as one of the pipeline targets, and early preclinical results